Related references
Note: Only part of the references are listed.Bayesian optimal phase II designs with dual-criterion decision making
Yujie Zhao et al.
PHARMACEUTICAL STATISTICS (2023)
Bayesian optimal phaseIIclinical trial design with time-to-event endpoint
Heng Zhou et al.
PHARMACEUTICAL STATISTICS (2020)
A review of spline function procedures in R
Aris Perperoglou et al.
BMC MEDICAL RESEARCH METHODOLOGY (2019)
A Bayesian paradigm for decision-making in proof-of-concept trials
Erik Pulkstenis et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2017)
BOP2: Bayesian optimal design for phase II clinical trials with simple and complex endpoints
Heng Zhou et al.
STATISTICS IN MEDICINE (2017)
Bayesian Design of Proof-of-Concept Trials
Roland Fisch et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2015)
A Bayesian design for phase II clinical trials with delayed responses based on multiple imputation
Chunyan Cai et al.
STATISTICS IN MEDICINE (2014)
Evidence-based clinical trial design for chronic pain pharmacotherapy: A blueprint for ACTION
Robert H. Dworkin et al.
PAIN (2011)
ACTION on the Prevention of Chronic Pain after Surgery Public-Private Partnerships, the Future of Analgesic Drug Development
Bob A. Rappaport et al.
ANESTHESIOLOGY (2010)
A Primer in Longitudinal Data Analysis
Garrett M. Fitzmaurice et al.
CIRCULATION (2008)
A predictive probability design for phase II cancer clinical trials
J. Lack Lee et al.
CLINICAL TRIALS (2008)
Cancer pain assessment in clinical trials. A review of the literature (1999-2002)
A Caraceni et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2005)
Selecting the number of knots for penalized splines
D Ruppert
JOURNAL OF COMPUTATIONAL AND GRAPHICAL STATISTICS (2002)
Bayesian two-stage designs for phase II clinical trials
SB Tan et al.
STATISTICS IN MEDICINE (2002)